Poor diabetic control, smoking, obesity and
hyperlipidaemia are some of the other risk factors of the condition.
of Patients Risk Factors Male Female Obesity 16 12
Hyperlipidaemia 17 13 Diabetes Mellitus 10 13 Total * 43 38 * The numbers don't add up to 60 since more than one sign/symptom was present in single patient.
He said people with cardiovascular disease along with the presence of one or more risk factors such as hypertension, diabetes,
hyperlipidaemia need early detection and treatment.
Individuals with diabetes or
hyperlipidaemia were particularly at risk over the latter period.
He has a background of hypertension,
hyperlipidaemia and was recently diagnosed with type 2 diabetes controlled on diet alone.
"We are now able to locally produce medication for cardiovascular diseases, psychiatric and neurological disorders, gastroenterological diseases, metabolic disorders such as
hyperlipidaemia and diabetes, central nervous system diseases, bacterial and viral infectious diseases, respiratory illnesses, asthma and allergies, bone and joint inflammation disorders, and urological diseases," he noted.
Madhukar Tanna, CEO of Pharmax, said: "We are now able to locally produce medication for cardiovascular diseases, psychiatric and neurological disorders, gastroenterological diseases, metabolic disorders such as
hyperlipidaemia and diabetes, central nervous system diseases, bacterial and viral infectious diseases, respiratory illnesses, asthma and allergies, bone and joint inflammation disorders, and urological diseases.
The anti-hyperglycaemic and antioxidant drug, metformin (Cicero et al., 2012; Chukwunonso Obi et al., 2016) that is widely used to treat type 2 diabetes mellitus was shown to ameliorate several types of liver diseases such as nonalcoholic fatty liver disease (NAFLD), improving liver injury in type 2 diabetes with
hyperlipidaemia (Matafome et al., 2011).
(29) The characteristics of insulin resistance include fasting hyperinsulinaemia and hyperglycaemia, postprandial hyperglycaemia, impaired glucose tolerance, impaired insulin tolerance, decreased glucose infusion rate, increased hepatic glucose production, loss of first phase secretion of insulin, increased glycosylated haemoglobin,
hyperlipidaemia, and hypoadiponectinaemia.
When managing dyslipidaemia, it is clinically useful to separate
hyperlipidaemia into two main categories, i.e.
The results suggested that cardiac embolic cerebral infarction was in correlation with
hyperlipidaemia.
Currently, cardiovascular disease (CVD) is the most significant cause of mortality, and
hyperlipidaemia is a major risk factor for atherosclerosis, which is the main pathogenetic pathway of CVD.
